INTERFERON AND ZINC COMBINATION THERAPY IN CHILDREN WITH CHRONIC HEPATITIS B INFECTION

被引:0
|
作者
Kuloglu, Z. [1 ]
Kirbas, G. [1 ]
Erden, E. [2 ]
Kansu, A. [1 ]
机构
[1] Ankara Univ, Dept Pediat Gastroenterol Hepatol & Nutr, TR-06100 Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Pathol, TR-06100 Ankara, Turkey
来源
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2010年 / 50卷
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E154 / E154
页数:1
相关论文
共 50 条
  • [31] Subacute thyroiditis during interferon therapy for chronic hepatitis B infection
    Ömür, Ö
    Daglyöz, G
    Akarca, U
    Özcan, Z
    CLINICAL NUCLEAR MEDICINE, 2003, 28 (10) : 864 - 865
  • [32] INTERFERON THERAPY IN CHRONIC HEPATITIS B
    不详
    LANCET, 1976, 2 (7995): : 1122 - 1124
  • [33] Interferon Therapy of Chronic Hepatitis B
    Brunetto, Maurizia Rossana
    Bonino, Ferruccio
    INTERVIROLOGY, 2014, 57 (3-4) : 163 - 170
  • [34] Efficacy of hepatitis B vaccination and interferon-α-2b combination therapy versus interferon-α-2b monotherapy in children with chronic hepatitis B
    Helvaci, M
    Kizilgunesler, A
    Kasirga, E
    Ozbal, E
    Kuzu, M
    Sozen, G
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) : 785 - 791
  • [35] Interferon α therapy in children with chronic hepatitis B -: Prognostic factors and therapy tolerance
    Liberek, A
    Luczak, G
    Bako, W
    Sikorska, G
    Rytlewska, M
    Szlagatys-Sidorkiewicz, A
    Góra-Gebka, M
    Bohdan, Z
    Korzon, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 170 - 171
  • [36] Serum zinc as a factor predicting response to interferon-α2b therapy in children with chronic hepatitis B
    Ebru Özbal
    Mehmet Helvaci
    Erhun Kasirga
    Figen Akdenizoglu
    Asli Kizilgüneşler
    Biological Trace Element Research, 2002, 90 : 31 - 38
  • [37] Serum zinc as a factor predicting response to interferon-α2b therapy in children with chronic hepatitis B
    Özbal, E
    Helvaci, M
    Kasirga, E
    Akdenizoglu, F
    Kizilgünesler, A
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2002, 90 (1-3) : 31 - 38
  • [38] Review article: the potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection
    Vigano, M.
    Invernizzi, F.
    Grossi, G.
    Lampertico, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (07) : 653 - 661
  • [39] The incidence and evolution of thyroid dysfunction during interferon-α therapy in children with chronic hepatitis B infection
    Kuloglu, Zarife
    Kansu, Aydan
    Berberoglu, Merih
    Adiyaman, Pelin
    Ocal, Gonul
    Girgin, Nurten
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2007, 20 (02): : 237 - 245
  • [40] The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis
    Xie, Qiao-Ling
    Zhu, Ying
    Wu, Ling-Hong
    Fu, Lin-Lin
    Xiang, Yan
    PLOS ONE, 2015, 10 (07):